150 related articles for article (PubMed ID: 28872976)
21. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
Ock CY; Nam AR; Lee J; Bang JH; Lee KH; Han SW; Kim TY; Im SA; Kim TY; Bang YJ; Oh DY
Gastric Cancer; 2017 Mar; 20(2):254-262. PubMed ID: 27147244
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of prognostic factors for the extent of vascularity of serous ovarian cancer on the basis of CD34 antigen expression].
Blok R; Blok K; Jeleń M; Gryboś M
Ginekol Pol; 2004 Feb; 75(2):91-8. PubMed ID: 15108579
[TBL] [Abstract][Full Text] [Related]
23. Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.
Xu X; Deng F; Lv M; Ren B; Guo W; Chen X
J Ovarian Res; 2016 Dec; 9(1):85. PubMed ID: 27912779
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer.
Scambia G; Testa U; Benedetti Panici P; Foti E; Martucci R; Gadducci A; Perillo A; Facchini V; Peschle C; Mancuso S
Br J Cancer; 1995 Feb; 71(2):354-6. PubMed ID: 7841052
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion.
Polat M; Senol T; Ozkaya E; Ogurlu Pakay G; Cikman MS; Konukcu B; Ozten MA; Karateke A
Clin Transl Oncol; 2016 May; 18(5):457-63. PubMed ID: 26289552
[TBL] [Abstract][Full Text] [Related]
26. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
27. Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma.
Tian Q; Lu B; Ye J; Lu W; Xie X; Wang X
J Int Med Res; 2016 Apr; 44(2):357-66. PubMed ID: 26880793
[TBL] [Abstract][Full Text] [Related]
28. Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.
Santos TD; Jammal MP; Silveira TP; Murta EFC; Nomelini RS
Pathologica; 2019 Jun; 111(2):62-66. PubMed ID: 31388197
[TBL] [Abstract][Full Text] [Related]
29. Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin 7.
Lambeck AJ; Crijns AP; Leffers N; Sluiter WJ; ten Hoor KA; Braid M; van der Zee AG; Daemen T; Nijman HW; Kast WM
Clin Cancer Res; 2007 Apr; 13(8):2385-91. PubMed ID: 17438097
[TBL] [Abstract][Full Text] [Related]
30. Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?
Mohapatra S; Saxena A; Gandhi G; Koner BC; Singh T; Ray PC
Clin Transl Oncol; 2015 Aug; 17(8):590-5. PubMed ID: 25740667
[TBL] [Abstract][Full Text] [Related]
31. [Concentration of soluble ligand for receptor CD30 (sCD30L)--marker of apoptosis in women with ovarian tumor].
Mielczarek-Palacz A; Kondera-Anasz Z; Sikora J; Sodowski K; Switała J; Kubina R
Ginekol Pol; 2009 Jul; 80(7):494-7. PubMed ID: 19697811
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer.
Hao W; Zhu Y; Zhou H
Med Oncol; 2013 Mar; 30(1):333. PubMed ID: 23269580
[TBL] [Abstract][Full Text] [Related]
33. Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.
Wouters MC; Komdeur FL; Workel HH; Klip HG; Plat A; Kooi NM; Wisman GB; Mourits MJ; Arts HJ; Oonk MH; Yigit R; de Jong S; Melief CJ; Hollema H; Duiker EW; Daemen T; de Bruyn M; Nijman HW
Clin Cancer Res; 2016 Feb; 22(3):714-24. PubMed ID: 26384738
[TBL] [Abstract][Full Text] [Related]
34. The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.
Seckin KD; Karslı MF; Yucel B; Bestel M; Yıldırım D; Canaz E; Akbayır O
Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():60-3. PubMed ID: 26683535
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients.
Lane D; Matte I; Rancourt C; Piché A
BMC Cancer; 2011 May; 11():210. PubMed ID: 21619709
[TBL] [Abstract][Full Text] [Related]
36. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.
Tas F; Oguz H; Argon A; Duranyildiz D; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(3):241-6. PubMed ID: 16110135
[TBL] [Abstract][Full Text] [Related]
37. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer.
Kim YW; Kim SK; Kim CS; Kim IY; Cho MY; Kim NK
Anticancer Res; 2014 Jul; 34(7):3481-7. PubMed ID: 24982357
[TBL] [Abstract][Full Text] [Related]
38. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
[TBL] [Abstract][Full Text] [Related]
39. Serum soluble Fas levels in ovarian cancer.
Hefler L; Mayerhofer K; Nardi A; Reinthaller A; Kainz C; Tempfer C
Obstet Gynecol; 2000 Jul; 96(1):65-9. PubMed ID: 10862844
[TBL] [Abstract][Full Text] [Related]
40. Expression of interleukine-8 as an independent prognostic factor for sporadic colon cancer dissemination.
Nastase A; Paslaru L; Herlea V; Ionescu M; Tomescu D; Bacalbasa N; Dima S; Popescu I
J Med Life; 2014 Jun; 7(2):215-9. PubMed ID: 25408728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
